In this webinar, we will talk about ECM remodeling as the common denominator of all fibro-inflammatory disorders. We will also discuss how ECM turnover may lead to better insight into disease mechanisms and a better biological understanding of individual patients and how we can best use this to guide drug development.

Finally, we delve into endotrophin, a collagen hormone in multi-organ diseases, and endotrophin in HFpEF, a potentially treatable high-risk endotype.

Watch the webinar

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.